universalsoli.blogg.se

Paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria











Nishimura Ji J, Hirota T, Kanakura Y, et al. Complement-induced procoagulant alteration of red blood cell membranes with microvesicle formation in paroxysmal nocturnal haemoglobinuria (PNH): Implication for thrombogenesis in PNH. Ninomiya H, Kawashima Y, Hasegawa Y, Nagasawa T. Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro. Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Nafa K, Mason PJ, Hillmen P, Luzzatto L, Bessler M. Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: Implications for paroxysmal nocturnal hemoglobinuria. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Maciejewski JP, Follmann D, Nakamura R, et al. Somatic mutations in paroxysmal nocturnal hemoglobinuria: A blessing in disguise? Cell 1997 88:1–4. Paroxysmal murine Hemoglobinuria(?): A model for human PNH. FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow. Glycosylphosphatidylinositol-anchor-deficient mice: Implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. GATA1-Cre mediates Piga gene inactivation in the erythroid/megakaryocytic lineage and leads to circulating red cells with a partial deficiency in glycosyl phosphatidylinositol-linked proteins (paroxysmal nocturnal hemoglobinuria type II cells). Jasinski M, Keller P, Fujiwara Y, Orkin SH, Bessler M. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. Natural history of paroxysmal nocturnal hemoglobinuria. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Superior growth of glycophosphatidylinositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo. Hum Mol Genet 1994 3:751–757.Ĭhen G, Kirby M, Zeng W, Young NS, Maciejewski JP. Genomic organization of the X-linked gene (PIG-A) that is mutated in paroxysmal nocturnal haemoglobinuria and of a related autosomal pseudogene mapped to 12q21.

paroxysmal nocturnal hemoglobinuria

Proc Natl Acad Sci USA 1999 96:5209–5214.īessler M, Hillmen P, Longo L, Luzzatto L, Mason PJ. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Leukemia 1996 10:1326–1330.Īraten DJ, Nafa K, Pakdeesuwan K, Luzzatto L.

paroxysmal nocturnal hemoglobinuria

Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: A tool for measuring the extent of the PNH clone. This process is experimental and the keywords may be updated as the learning algorithm improves.Īlfinito F, Del Vecchio L, Rocco S, Boccuni P, Musto P, Rotoli B. These keywords were added by machine and not by the authors. Key Words: Aplastic anemia bone marrow failure CD55/DAF CD59/MIRL clonal hematopoiesis complement-mediated lysis escape theory GPI anchor GPI-linked molecules intravascular hemolysis pancytopenia paroxysmal nocturnal hemoglobinuria PIG-A gene T-cell clonality thrombophilia. This review highlights the molecular pathophysiology of the disease and analyses the mechanisms responsible for the expansion of a hematopoietic clone, which is paradoxically less vital as compared with normal cells. However, many other defects are present on PNH cell membrane, involving red cells, granulocytes, monocytes, and platelets, leading to tendency to infection and thrombosis. Some GPI-linked molecules are responsible for cell defense against activated complement this is why PNH red cells are hypersensitive to complement attack and are continuously destroyed in the circulation, with paroxysmal exacerbations. The mutated cell is unable to build the GPI anchor, which is needed to bind a number of molecules on the outer cell surface. Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic disorder arising from a mutation in the X chromosome-linked PIG-A gene.













Paroxysmal nocturnal hemoglobinuria